Literature DB >> 11903494

Serum amyloid A and high-density lipoprotein cholesterol: serum markers of inflammation in sarcoidosis and other systemic disorders.

A Salazar1, X Pintó, J Mañá.   

Abstract

Hypocholesterolemia has been observed in several inflammatory diseases such as rheumatoid arthritis, myeloproliferative disorders, systemic lupus erythematosus and sarcoidosis. Serum amyloid A is an acute-phase reactant that is related to the high-density lipoprotein cholesterol. This review discusses the relationship between the activation of the cells of the monocyte-macrophage system, determined by the serum amyloid A levels, and the lipid metabolism, measured as alterations in plasma lipoprotein concentrations. The mechanisms of this association during acute inflammation are also discussed in this review.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11903494     DOI: 10.1046/j.1365-2362.2001.00913.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  15 in total

1.  Gene expression profiling in fetal, aged, and Alzheimer hippocampus: a continuum of stress-related signaling.

Authors:  Walter J Lukiw
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

2.  Screening and evaluating the mimic peptides as a useful serum biomarker of ankylosing spondylitis using a phage display technique.

Authors:  Min Wang; Xianping Li; Jingwei Chen; Yong Zhou; Hong Cao; Xiang Wu; Hongmin Jiang
Journal:  Rheumatol Int       Date:  2010-03-19       Impact factor: 2.631

3.  Serum lipidomics in diagnostics of sarcoidosis.

Authors:  Beata Toczylowska; Dariusz Jastrzebski; Sabina Kostorz; Elzbieta Zieminska; Dariusz Ziora
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

4.  Serum amyloid A levels are associated with polymorphic variants in the serum amyloid A 1 and 2 genes.

Authors:  Kayleigh Griffiths; Alexander P Maxwell; Rachel V McCarter; Patrick Nicol; Ruth E Hogg; Mark Harbinson; Gareth J McKay
Journal:  Ir J Med Sci       Date:  2019-03-09       Impact factor: 1.568

5.  Associations of lipoprotein subclasses and oxidative stress status in pulmonary and pulmonary plus extrapulmonary sarcoidosis.

Authors:  Jasmina Ivaniševic; Jelena Vekic; Aleksandra Zeljkovic; Aleksandra Stefanovic; Jelena Kotur-Stevuljevic; Vesna Spasojevic-Kalimanovska; Slavica Spasic; Violeta Vucinic-Mihailovic; Jelica Videnovic-Ivanov; Zorana Jelic-Ivanovic
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

Review 6.  Identifying Novel Biomarkers in Sarcoidosis Using Genome-Based Approaches.

Authors:  Nancy Casanova; Tong Zhou; Kenneth S Knox; Joe G N Garcia
Journal:  Clin Chest Med       Date:  2015-09-26       Impact factor: 2.878

7.  Altered pattern of lipids in plasma and erythrocyte membranes of rheumatoid arthritis patients.

Authors:  D Vijayakumar; K Suresh; S Manoharan
Journal:  Indian J Clin Biochem       Date:  2005-01

8.  SNP Variants in Major Histocompatibility Complex Are Associated with Sarcoidosis Susceptibility-A Joint Analysis in Four European Populations.

Authors:  Annika Wolin; Elisa Laura Lahtela; Verneri Anttila; Martin Petrek; Johan Grunewald; Coline H M van Moorsel; Anders Eklund; Jan C Grutters; Vitezslav Kolek; Frantisek Mrazek; Amit Kishore; Leonid Padyukov; Anne Pietinalho; Marcus Ronninger; Mikko Seppänen; Olof Selroos; Marja-Liisa Lokki
Journal:  Front Immunol       Date:  2017-04-19       Impact factor: 7.561

9.  Preliminary characterizations of a serum biomarker for sarcoidosis by comparative proteomic approach with tandem-mass spectrometry in ethnic Han Chinese patients.

Authors:  Yuan Zhang; Xianqiu Chen; Yang Hu; Shanshan Du; Li Shen; Yifan He; Yuxuan Zhang; Xia Zhang; Huiping Li; Rex C Yung
Journal:  Respir Res       Date:  2013-02-11

10.  Serum amyloid a as a useful indicator of disease activity in patients with ankylosing spondylitis.

Authors:  Sang Youn Jung; Min-Chan Park; Yong-Beom Park; Soo-Kon Lee
Journal:  Yonsei Med J       Date:  2007-04-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.